DNA-Guided Medicine and Portal

The U.S. Food and Drug Administration has identified DNA typing as a powerful means to enhance human health. DNA typing helps to pinpoint the inherited factors that influence how much medicine we need to take as well as the probability of side effects. In fact, a report in the Journal of the American Medical Association estimated that over 100,000 Americans die, and millions more end up in the hospital, each year from harmful drug reactions.

Now, with the HILOmet tests, healthcare providers have the ability to personalize drug therapy and increase drug safety for a wide range of patients including:

  • People experiencing drug intolerance, side effects, treatment resistance or a lack of drug effectiveness.
  • Those who are treated with drug combinations or with a history of drug sensitivities.

The results from your test are delivered to your clinician through our Personalized Health Portal, a secure web-based interface that provides information on over 250 different medications. These include 130 neuro-psychiatric drugs (to treat depression, autism, bipolar disorder, pain, attention deficit disorders, anxiety, insomnia) and 120 cardio-metabolic drugs (to treat high blood pressure, diabetes, blood clots, acid reflux, sexual dysfunction, asthma, arrhythmias). Guidance is provided based on your ability to metabolize your medicine, the appropriate dose and the potential for drug interactions. For more on the features of the Personalized Health Portal, click here.

Laboratory of Personalized Health (LPH)

Established in 2005 as a Division of Genomas, LPH is a high-complexity clinical DNA testing center. LPH is a certified provider of clinical laboratory diagnostics by the Centers for Medicare and Medicaid Services (CMS). LPH is nationally licensed under CLIA (Clinical Laboratory Improvement Amendments) and licensed additionally by the States of Connecticut, New York, Rhode Island, Florida, and California. HILOmet tests have been used by more than 400 clinicians in Connecticut who have referred nearly 5,000 patients (as of March 2013). For more on the LPH credentials, click here.

The HILOmet tests and interpretation guidelines have been developed in partnership with the Institute of Living and Hartford Hospital, a major research-based New England medical center. The HILOmet PhyzioType System has been extensively published and presented at professional meetings. For more on our research and publications, click here.